Citius Pharmaceuticals (CTXR)
(Delayed Data from NSDQ)
$0.65 USD
-0.02 (-2.86%)
Updated May 17, 2024 04:00 PM ET
After-Market: $0.65 0.00 (0.25%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.05 | 0.00% |
Earnings Summary
For their last quarter, Citius Pharmaceuticals (CTXR) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.06 per share. This reflects a positive earnings surprise of 16.67%. Look out for CTXR's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.05 per share, reflecting a year-over-year increase of 16.67%.
Earnings History
Price & Consensus
Zacks News for CTXR
Citius (CTXR) Posts Top-Line Data From Pivotal Lymphoma Study
CTXR: What are Zacks experts saying now?
Zacks Private Portfolio Services